GRC Surgical was acquired by Bunzl plc in 2022 and is now operating as part of Bunzl Asia Pacific’s business operations. GRC Surgical marks a significant milestone in Bunzl’s rapid expansion into healthcare markets in alignment with the company’s wider business strategy. GRC Surgical’s philosophy is to offer sophisticated technology made simple, with a focus on providing advanced detection systems for ease of use and accuracy.
GRC Surgical supplies a range of healthcare equipment and is also the exclusive Australian distributor of Neoprobe, a cutting-edge technology system designed to assist surgeons in performing the Sentinel Node Biopsy procedure.
GRC Surgical also provides services such as GRC care, providing the only backup service centre in Australia capable of performing testing and repairs without the need to send devices outside Australia. With NATA-approved service centres and fully trained and accredited service personnel, GRC Surgical provides its customers with further reassurance. GRC CARE also provides specialized testing in Australia for all gamma detection systems, including a full 12-month warranty on all parts, services, and repairs outside of the original manufacturer’s one-year warranty. In addition to servicing gamma detection systems, GRC Surgical provides education and support for breast cancer surgery, along with technology updates.
GRE’s success is built on its dedication to providing:
• GRC CARE service all gamma detection systems
• NATA approved service centre
• Performance testing and preventative maintenance
• A full performance & service report provided
• Loan systems available, no down time for theatres
• Quick turnaround time